FDA plans to launch communications pilot for promising rare disease gene therapies

The head of the US Food and Drug Administration’s (FDA) biologics center said the agency will soon launch a pilot to apply the lessons it learned from the COVID-19 pandemic to accelerate development of certain gene therapies for rare diseases.